As expected, metformin treatment upregulated expression levels of INS-I, INS-II, MAFA, GLUT-2, and PDX-1 in DCM rats which was associated with β-cell restoration, consistent with its established role as both an insulin sensitizer and promoter of insulin secretion [50]. Here, MAFA is linked to familial dilated cardiomyopathy.